Anthony Magliocco MD’s Post

View profile for Anthony Magliocco MD, graphic

President and CEO at Protean BioDiagnostics Inc

The growing gap in access to precision medicine for cancer patients treated in community settings is a critical challenge facing the healthcare system. Protean BioDiagnostics aims to bridge this divide by offering rapid deployment of cutting-edge companion diagnostics. Their innovative framework simplifies access to complex diagnostics, revolutionizing precision oncology in communities. Learn more about Protean's mission to transform cancer care for underserved patients: [Link to webinar](https://lnkd.in/e9UfDei) #PrecisionMedicine #Oncology #CancerCare #HealthcareInnovation

LIVE WEBINAR: Closing the Precision Medicine Gap Using Whole Exome Sequencing - Bioinformatics Software | QIAGEN Digital Insights

LIVE WEBINAR: Closing the Precision Medicine Gap Using Whole Exome Sequencing - Bioinformatics Software | QIAGEN Digital Insights

digitalinsights.qiagen.com

To view or add a comment, sign in

Explore topics